← All stocks

VERACYTE, INC.

VCYT Scheduled selling only
CIK 0001384101 #1647 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.15M
$1.15M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 8 sales
Net
−$1.15M
$0.00 against sales at will

By person

15 insiders · 8 transactions
25.2×

Marc Stapley holds 25.2 times base salary in stock. $17.69M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marc Stapley last reported holding, valued at $40.95, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Febbo Phillip G.
Chief Scientific & Med Officer
$564.41K (2) scheduled
−$564.41K
133,048
0.1655%
$5.45M
+42.9%
Holstein Jens
Director
$204.75K (1) scheduled
−$204.75K
27,471
0.0342%
$1.12M
−1.5%
Chambers Rebecca
Chief Financial Officer
$157.39K (2) scheduled
−$157.39K
166,025
0.2065%
$6.80M
+18.8%
McGuire Annie
EVP, General Counsel
$140.21K (2) scheduled
−$140.21K
131,160
0.1632%
$5.37M
+38.1%
Bhanji Muna
Director
$80.10K (1) scheduled
−$80.10K
42,718
0.0531%
$1.75M
+23.5%
Stapley Marc
Chief Executive Officer
432,073
0.5375%
$17.69M
+34.7%
Leite John
Global Chief Commercial Off
128,344
0.1597%
$5.26M
+68.5%
EPSTEIN ROBERT S
Director
57,718
0.0718%
$2.36M
+29.4%
Barr Eliav
Director
56,461
0.0702%
$2.31M
+34.9%
Haas Kevin Richard
Chief Dev and Tech Officer
44,221
0.0550%
$1.81M
Wygant Jonathan
VP, Chief Accounting Officer
43,226
0.0538%
$1.77M
−12.4%
JONES EVAN/ FA
Director
34,634
0.0431%
$1.42M
−12.4%
Shafer David Brent
Director
31,100
0.0387%
$1.27M
+88.4%
Miller Thomas F.
Director
31,100
0.0387%
$1.27M
+88.4%
EASTHAM KARIN
Director
15,097
0.0188%
$618.21K
−54.6%
Insider
Date
Role
Action
Shares
Price
Amount
Holstein Jens
14 Sep 2026
Director
Sold on a plan
5,000
$40.95
$204.75K
McGuire Annie
4 Sep 2026
EVP, General Counsel
Sold on a plan
1,100
$43.67
$48.04K
McGuire Annie
4 Sep 2026
EVP, General Counsel
Sold on a plan
2,154
$42.79
$92.17K
Chambers Rebecca
4 Sep 2026
Chief Financial Officer
Sold on a plan
1,175
$43.71
$51.36K
Chambers Rebecca
4 Sep 2026
Chief Financial Officer
Sold on a plan
2,477
$42.81
$106.03K
Febbo Phillip G.
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
2,705
$43.66
$118.11K
Febbo Phillip G.
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
10,405
$42.89
$446.30K
Bhanji Muna
1 Sep 2026
Director
Sold on a plan
1,864
$42.97
$80.10K

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 24,561
History held since 8 Dec 2016